Stock Chart

ACXP

$1.27 +0.79%
Score: 41.6 HOLD
Pro
Screener
Vol: 0.89x (vs SPY: 0.9x | vs QQQ: 0.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Falling Wedge Bullish scenario quality 63/100
Measured-move target $1.3 (+2.2%) · apex ~14 bars ahead
Historically breaks up 63% of the time; target hit in 75% of up-breaks (n=385)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About ACXP - Acurx Pharmaceuticals, Inc. Common Stock

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Key Statistics

Market Cap $5M

More ACXP Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This ACXP stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ACXP's price movements with trendlines, gamma walls, and key support/resistance levels.